Candidiasis, Mucocutaneous
BASICS
BASICS

BASICS
DESCRIPTION
DESCRIPTION
DESCRIPTION
- Heterogeneous group of mucocutaneous infections with commensal Candida species
- Characterized by superficial infection of the skin, mucous membranes, and nails
- >20 Candida species cause infection in humans. Candida albicans is responsible for 70% of fungal infections worldwide.
- Candida auris is an emerging global pathogen with a high propensity to develop drug resistance (1).
- Candidiasis affects:
- Aerodigestive system
- Oropharyngeal candidiasis (thrush): mouth, pharynx
- Angular cheilitis: corner of the mouth
- Esophageal candidiasis
- Gastritis and/or ulcers, associated with thrush; alimental or perianal
- Other systems
- Candida vulvovaginitis: vaginal mucosa and/or vulvar skin
- Candidal balanitis: glans of the penis
- Candidal paronychia: nail bed or nail folds
- Interdigital candidiasis: webs of the digits
- Candidal diaper dermatitis and intertrigo (within skin folds)
- Synonym(s): monilia; thrush; yeast; intertrigo
ALERT
Vaginal antifungal creams and suppositories can weaken condoms and diaphragms.
Pregnancy Considerations
- Vaginal candidiasis is common during pregnancy—extend treatment (typically a full 7-day course).
- Vaginal yeast infection at birth increases the risk of newborn thrush but is of no overall harm to baby.
EPIDEMIOLOGY
EPIDEMIOLOGY
EPIDEMIOLOGY
- Common in the United States; particularly with immunodeficiency and/or uncontrolled diabetes
- Age considerations
- Infants and seniors: thrush and cutaneous infections (infant diaper rash)
- Women (prepubertal through postmenopausal): yeast vaginitis
Incidence
Incidence
Incidence
Unknown—mucocutaneous candidiasis is common in immunocompetent patients. Complication rates are low.
Prevalence
Prevalence
Prevalence
Candida species are normal flora of oral cavity, GI tract that are present in >70% of the U.S. population.
ETIOLOGY AND PATHOPHYSIOLOGY
ETIOLOGY AND PATHOPHYSIOLOGY
ETIOLOGY AND PATHOPHYSIOLOGY
C. albicans (responsible for 80–92% vulvovaginal and >80% of oral isolates); altered cell–mediated immunity against Candida species (either transient or chronic) increases susceptibility to infection.
Genetics
Genetics
Genetics
Chronic mucocutaneous candidiasis is a heterogeneous, genetic syndrome that typically presents in infancy.
RISK FACTORS
RISK FACTORS
RISK FACTORS
- Immune suppression (antineoplastic treatments, transplant patients, cellular immune defects, HIV/AIDS)
- Malignant diseases
- Corticosteroid use
- Smoking and alcoholism
- Hyposalivation (Sjögren disease, drug-induced xerostomia, radiotherapy)
- Broad-spectrum antibiotic therapy
- Douches, chemical irritants, birth control pills, intrauterine devices, and concurrent vaginitides
- Denture wear, poor oral hygiene
- Endocrine alterations (diabetes mellitus, pregnancy, renal failure, hypothyroidism)
- Uncircumcised men at higher risk for balanitis
GENERAL PREVENTION
GENERAL PREVENTION
GENERAL PREVENTION
- Use antibiotics and steroids judiciously; rinse mouth after using inhaled steroids.
- Minimize perineal moisture (wear cotton underwear; frequent diaper changes; avoid douching).
- Clean dentures often; use well-fitting dentures and remove them during sleep.
- Optimize glycemic control in diabetics.
- Preventive regimens during cancer treatments, especially in patients with hematologic malignancies
- Treat with HAART in HIV-infected patients; antifungal prophylaxis is not recommended unless HIV-infected adults have frequent or severe recurrences.
COMMONLY ASSOCIATED CONDITIONS
COMMONLY ASSOCIATED CONDITIONS
COMMONLY ASSOCIATED CONDITIONS
HIV, diabetes mellitus, cancer, and other immunosuppressive conditions
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.